Uba G, Pachorek D, Bernstein J, Garabrant D H, Balmes J R, Wright W E, Amar R B
Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles.
Am J Ind Med. 1989;15(1):91-101. doi: 10.1002/ajim.4700150110.
We conducted a prospective evaluation of pulmonary function and respiratory symptoms among 103 medical students exposed to formaldehyde over a 7-month period to determine the incidence of bronchoconstriction and respiratory symptoms in response to exposure. Time-weighted average formaldehyde exposures were generally less than 1 part per million (ppm) and peak exposures were less than 5 ppm. Acute symptoms of eye and upper respiratory irritation were significantly associated with exposure. There was no pattern of bronchoconstriction in response to exposure after either 2 weeks or 7 months. Twelve subjects had a history of asthma; they were no more likely to have symptoms of respiratory irritation or changes in pulmonary function than those without such a history. These findings are consistent with previous case reports that indicate exposure to formaldehyde vapor at levels that are commonly encountered in occupational and residential settings do not commonly cause significant bronchoconstriction, even among subjects with preexisting asthma.
我们对103名在7个月期间接触甲醛的医学生进行了肺功能和呼吸道症状的前瞻性评估,以确定因接触甲醛而导致支气管收缩和呼吸道症状的发生率。甲醛的时间加权平均暴露量一般低于百万分之一(ppm),峰值暴露量低于5 ppm。眼部和上呼吸道刺激的急性症状与暴露显著相关。在接触2周或7个月后,均未出现因接触甲醛而导致支气管收缩的模式。12名受试者有哮喘病史;与没有此类病史的受试者相比,他们出现呼吸道刺激症状或肺功能变化的可能性并不更高。这些发现与之前的病例报告一致,表明在职业和居住环境中常见的甲醛蒸汽暴露水平下,即使是在已有哮喘的受试者中,通常也不会导致明显的支气管收缩。